Yang Xu is an associate in the Intellectual Property Practice Group. She advises clients in the biotechnology and pharmaceutical industries on a variety of intellectual property issues, including worldwide patent portfolio development, patent prosecution, due diligence, and litigation support.
Prior to joining the firm, Yang worked as a patent agent at an international law firm in Silicon Valley, where she worked with clients in the fields of pharmaceuticals, biotechnology, geochemical prospecting, and medical devices. She prepared and prosecuted patent applications in the United States and many foreign jurisdictions, helping clients obtain robust and enforceable patent protection around the world. Yang also performed analyses for advising clients in connection with transactions, such as mergers and acquisitions, licenses, and venture financings, and conducted analyses related to patentability, validity, non-infringement, freedom-to-operate and Orange Book listing matters.
Yang obtained her Ph.D. from the Scripps Research Institute (TSRI), La Jolla, and her graduate research focused on development of small molecule therapeutics and catalytic monoclonal antibodies useful for the treatment of various disorders.
Val S. Goodfellow, Colin J. Loweth, Satheesh B. Ravula, Torsten Wiemann, Thong Nguyen, Yang Xu, Daniel E. Todd, David Sheppard, Scott Pollack, Oksana Polesskaya, Daniel F. Marker, Stephen Dewhurst, and Harris A. Gelbard Discovery, Synthesis and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3 J. Med. Chem. 2013, 56, 8032.
Yang Xu, Mark S. Hixon, Philip E. Dawson, and Kim D. Janda Development of a FRET Assay for Monitoring of HIV gp41 Core Disruption Journal of Organic Chemistry 2007, 72, 6700.
Yang Xu, Mark Hixson, Laura McAllister, Noboru Yamamoto, Paul Wentworth Jr., Kim D. Janda Antibody-catalyzed Anaerobic Destruction of Methamphetamine: A New Direction in Immunopharmacotherapy Proceedings of the National Academy of Sciences, USA, 2007, 104, 3681.
Sandra De Lamo Marin, Yang Xu, Michael M. Meijler, and Kim. D. Janda Antibody catalyzed hydrolysis of a quorum sensing signal found in gram-negative bacteria Bioorganic and Medicinal Chemistry, 2007, 17, 1549.
Yang Xu, Jin Shi, Noboru Yamamoto, Jason A. Moss, Peter K. Vogt, Kim D. Janda A Credit Card Library Approach for Disrupting Protein-Protein Interactions Bioorganic and Medicinal Chemistry 2006, 14, 2660.
Yang Xu, Noboru Yamamoto, Diana I. Ruiz, Diane S. Kubitz, Kim D. Janda Squaric Monoamide Monoester as a New Class of Reactive Immunization Hapten for Catalytic Antibodies Bioorganic and Medicinal Chemistry Letters 2006, 15, 4304.
Yang Xu, Hong Lu, Jack P. Kennedy, Xuxia Yan, Laura A. McAllister, Noboru Yamamoto, Jason A. Moss, Grant E. Boldt, Shibo Jiang, and Kim D. Janda Evaluation of Credit Card Libraries for Inhibition of HIV-1 gp41 Fusogenic Core Formation Journal of Combinatorial Chemistry 2006, 8, 531.
Tobin J. Dickerson, Claude J. Rogers, Albert E. Beuscher IV, Noboru Yamamoto, Yang Xu, Arthur J. Olson, and Kim D. Janda Discovery of Inhibitors of the Amyloidogenic Effect of Acetylcholinesterase Through Computational Refinement of a Directed Library Biochemistry 2005, 44, 14845.
Yang Xu, Noboru Yamamoto, Kim D. Janda Catalytic Antibodies-Hapten Design Strategies and Screening Methods Bioorganic and Medicinal Chemistry 2004, 12, 5247.
Yang Xu, Laurent Jaquinod, Anura Wickramasinghe and Kevin M. Smith Near-IR Absorption of Porphyrin Methylcarbocations Tetrahedron letters 2003, 44, 7753.
Karl M. Kadish, Min Lin, Eric Van Caemelbecke, Guido De Stefano, Craig J. Medforth, Daniel J. Nurco, Nora Y. Nelson, Bénédicte Krattinger, Cinzia M. Muzzi, Laurent Jaquinod, Yang Xu, David C. Shyr, Kevin M. Smith, and John A. Shelnut Influence of Electronic and and Structural Effects on the Oxidative Behavior of Nickel Porphyrins Inorg. Chem., 2002, 41 (25), 6673–6687.